// Auto-generated - do not edit
export const substanceName = "25P-NBOMe";
export const sources = [{"id":"protestkit","fileName":"PROTESTKIT - 25P-NBOMe.json","displayName":"Protest Kit","size":2723},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - 25P-NBOMe.md","displayName":"TripSit Factsheets","size":832},{"id":"wikipedia","fileName":"WIKIPEDIA - 25P-NBOMe.md","displayName":"Wikipedia","size":1073}];
export const contents: Record<string, string> = {
  "protestkit": `{
  "url": "https://en.wikipedia.org/wiki/2C-P-NBOMe",
  "experiencesUrl": "https://www.reddit.com/search/?q=2C-P-NBOMe",
  "name": "2C-P-NBOMe",
  "aliases": [],
  "aliasesStr": "",
  "summary": "This is an obscure substance with no entry in PsychoanutWiki or TripSit. Reliable data is unavailable.",
  "reagents": null,
  "classes": {
    "chemical": [
      "Substituted phenethylamines"
    ],
    "psychoactive": [
      "Psychedelic"
    ]
  },
  "toxicity": null,
  "addictionPotential": null,
  "tolerance": null,
  "crossTolerances": null,
  "roas": [],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Caution"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Caution"
    },
    {
      "name": "Alcohol",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Amphetamines",
      "status": "Unsafe"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Caution"
    },
    {
      "name": "Cannabis",
      "status": "Caution"
    },
    {
      "name": "Cocaine",
      "status": "Unsafe"
    },
    {
      "name": "DMT",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "DOx",
      "status": "Caution"
    },
    {
      "name": "DXM",
      "status": "Unsafe"
    },
    {
      "name": "GHB/GBL",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Gabapentinoids",
      "status": "Caution"
    },
    {
      "name": "Ketamine",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "LSD",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MAOIs",
      "status": "Caution"
    },
    {
      "name": "MDMA",
      "status": "Caution"
    },
    {
      "name": "MMC class",
      "status": "Unsafe"
    },
    {
      "name": "MXE",
      "status": "Caution"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Unsafe"
    },
    {
      "name": "Poppers",
      "status": "Caution"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Tramadol",
      "status": "Unsafe"
    }
  ],
  "effects": null,
  "categorized_effects": {
    "Physical effects": [],
    "Mental effects": [],
    "Sensory effects": [],
    "Uncategorized effects": []
  }
}`,
  "tripsit-factsheets": `# 25P-NBOMe
*Source: TripSit Factsheets (tripsit.me)*

## Summary

A rare potent psychedelic drug with similar effects and risks to others in the NBOMe class. The substance was first sold in mid-late 2012, and resurfaced in early 2015.

## Classification
- **Categories:** psychedelic, research-chemical, tentative

## Dosage

### Oral
- **Common:** 450-700ug
- **Light:** 250-450ug
- **Strong:** 700-1500ug
- **Threshold:** 100-250ug

## Duration
- **Onset:** 25-40 minutes
- **Duration:** 7-14 hours
- **After Effects:** 1-16 hours

## Effects
- Euphoria
- empathy
- insight
- brightened colour
- Closed/Open eye visuals
- enhanced tactile sensation
- mental/physical stimulation
- decreased appetite
- pupil dilation
- restlessness
- change in perception
- ego softening
- sweating/chills
- muscle tension
- confusion
- insomnia
`,
  "wikipedia": `# 25P-NBOMe
*Source: https://en.wikipedia.org/wiki/25P-NBOMe*

25P-NBOMe (2C-P-NBOMe, NBOMe-2C-P) is a derivative of the phenethylamine 2C-P. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT2A receptor. 25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

## Use and effects

The dose range of 25P-NBOMe has been given as 0.1 to 1.5 mg sublingually, with a typical dose estimate of 0.6 mg.

## Toxicity and harm potential

### Neurotoxic and cardiotoxic actions

### Emergency treatment

## Interactions

## Pharmacology

### Pharmacodynamics

25P-NBOMe is a potent agonist of the serotonin 5-HT2 receptors, including the serotonin 5-HT2A receptor.

## History

25P-NBOMe was first described in the scientific literature by 2012.

## Society and culture

### Legal status

#### United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
`,
};
